Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0M7DE
|
||||
Former ID |
DNC010663
|
||||
Drug Name |
N-(1-benzofuran-3-ylmethyl)sulfamide
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C9H10N2O3S
|
||||
Canonical SMILES |
C1=CC=C2C(=C1)C(=CO2)CNS(=O)(=O)N
|
||||
InChI |
1S/C9H10N2O3S/c10-15(12,13)11-5-7-6-14-9-4-2-1-3-8(7)9/h1-4,6,11H,5H2,(H2,10,12,13)
|
||||
InChIKey |
XOBOZYKTCAJRGO-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Carbonic anhydrase II | Target Info | Inhibitor | [1] | |
KEGG Pathway | Nitrogen metabolism | ||||
Proximal tubule bicarbonate reclamation | |||||
Collecting duct acid secretion | |||||
Gastric acid secretion | |||||
Pancreatic secretion | |||||
Bile secretion | |||||
NetPath Pathway | IL4 Signaling Pathway | ||||
EGFR1 Signaling Pathway | |||||
Reactome | Erythrocytes take up carbon dioxide and release oxygen | ||||
Erythrocytes take up oxygen and release carbon dioxide | |||||
Reversible hydration of carbon dioxide | |||||
WikiPathways | Reversible Hydration of Carbon Dioxide | ||||
Uptake of Carbon Dioxide and Release of Oxygen by Erythrocytes | |||||
Uptake of Oxygen and Release of Carbon Dioxide by Erythrocytes | |||||
References | |||||
REF 1 | J Med Chem. 2009 Dec 10;52(23):7528-36.Novel, broad-spectrum anticonvulsants containing a sulfamide group: advancement of N-((benzo[b]thien-3-yl)methyl)sulfamide (JNJ-26990990) into human clinical studies. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.